RVP

Retractable Technologies, Inc. RVP

RVP
Retractable Technologies, Inc. NXGL
NEXGEL, Inc. HBIO
Harvard Bioscience, Inc. NXL
Nexalin Technology, Inc. NRSN
NeuroSense Therapeutics Ltd. FEMY
Femasys Inc. NRXS
NeurAxis, Inc. SCYX
SCYNEXIS, Inc. XCUR
Exicure, Inc. CLGN
CollPlant Biotechnologies Ltd.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RVP NXGL HBIO NXL NRSN FEMY NRXS SCYX XCUR CLGN
6M 23.43 % -35.83 % 38.93 % -36.50 % -59.73 % -26.47 % 51.19 % -19.71 % 7.21 % 12.17 %
YTD 11.18 % -59.79 % -64.97 % -80.22 % -30.67 % -34.28 % 62.13 % -59.22 % -60.80 % -59.37 %
1Y 28.06 % -67.85 % -66.13 % -77.95 % -37.22 % -37.14 % 58.75 % -42.03 % -65.51 % -56.64 %
3Y -50.81 % 30.51 % -72.43 % -20.12 % -36.22 % -23.91 % -36.50 % -61.10 % -4.03 % -81.55 %
5Y -92.99 % -56.25 % -83.54 % -71.78 % -80.26 % -93.98 % -36.50 % -92.00 % -97.86 % -85.34 %
10Y -71.05 % -56.25 % -80.57 % -71.78 % -80.26 % -93.98 % -36.50 % -98.98 % -98.72 % -82.80 %
From the beginning -93.60 % -56.25 % -91.13 % -71.78 % -80.26 % -93.98 % -36.50 % -99.34 % -98.72 % -82.80 %

Dividend